Analysts anticipate Rockwell Medical to report an earnings per share (EPS) of $0.01. The market awaits Rockwell Medical's ...

AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to ...

During my three-year ARISE fellowship, I worked closely with the ESRF and experienced working with ARINAX—the company that ...

A mechanical engineer by trade, Garden Spot High School graduate Josh Stuckey is a former designer of vehicle engines and child car seats who is now 17 years into a quest for the perfect home ice ...

Iovance Biotherapeutics is a biopharmaceutical company that develops and commercializes cancer immunotherapy products. In February 2024, Amtagvi, also known as lifileucel, became the first FDA ...

S4V2 will be tested for safety and preliminary efficacy in approximately 120 healthy Shigella -naïve participants aged 18 to 50 years at three sites in the United States. The study, sponsored and ...

It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in ...

Overview: Taysha Gene Therapies, Inc. is a gene therapy company that develops and commercializes adeno-associated virus-based ...

GS E&R has commercialized a new solution for predicting wind power intermittency. The breakthrough, according to the ...

Corporate insiders own 13.88% of the company’s stock. Zai Lab Limited develops and commercializes therapies to treat oncology ...

Nuwellis (NASDAQ:NUWE – Get Free Report) is set to announce its earnings results before the market opens on Monday, November ...